Abstract
Much is known about the replication of the human immunodeficiency virus type 1 (HIV-1) from the time of cell attachment to the release of mature virions (Figure 1), and drugs that interfere with many of the steps in HIV replication have been developed and tested in vitro. These drugs include inhibitors of reverse transcriptase, protease, and a regulatory protein, Tat (Table 1). Inhibitors of reverse transcriptase can prevent the spread of infectious virus to new cells but do not interfere with the replication of HIV genomes that are integrated into the host genome. Two of the most promising agents target . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
